Crossmark

Impact of the US Accelerated Approval for New Anticancer Drugs on Time to Verification of Benefit and Regulatory Approval in the EU and Japan

Published Online: 2023-10-03

Published Print: 2024-01

Authors

Ito, Akira https://orcid.org/0009-0005-6515-219X
Narukawa, Mamoru
License Information

Text and Data Mining valid from 2023-10-03

Version of Record valid from 2023-10-03
More Information

Article History

Received: 17 March 2023

Accepted: 5 September 2023

First Online: 3 October 2023

Declarations

:

: Akira Ito is an employee of Daiichi Sankyo Co., Ltd., Tokyo, Japan.

Document is current